Literature DB >> 23296104

Comparison of tolerance to morphine-induced respiratory and analgesic effects in mice.

Wasseem Mohammed1, Hisham Alhaddad, Nicolas Marie, Floriane Tardy, Florence Lamballais, Patricia Risède, Florence Noble, Frédéric J Baud, Bruno Mégarbane.   

Abstract

Morphine is responsible for severe poisonings in chronically treated patients. We hypothesize that toxicity could be related to the development of weaker tolerance for morphine-induced deleterious respiratory effects in comparison to analgesic effects. Our objectives were to compare tolerance to both effects in mice and investigate possible mechanisms for such possible differences. Tolerance to morphine-induced analgesia and respiratory effects was assessed using hot plate response latencies and plethysmography, respectively. Mechanisms of tolerance were investigated using binding studies to mu-opioid receptors (MOR) and adenylate cyclase (AC) activity measurement in homogenates of cell membranes from the periaqueductal gray region (PAG) and brainstem. Morphine (2.5 mg/kg) was responsible for analgesia with significant increase in inspiratory time. Acute tolerance to analgesia (p<0.01) and effects on respiratory frequency (p<0.05) was observed in mice pre-treated with 100 mg/kg morphine in comparison to saline. Following repetitive administration (2.5 mg/kg/day during 10 days), we observed a 13-fold increase in the effective dose-50% (ED₅₀) of morphine-induced analgesia in comparison to a 2- or 4-fold increase in the ED₅₀ of its related increase in inspiratory time determined in air and 4% CO₂, respectively. No significant alteration in MOR expression was observed in either PAG or brainstem following repeated morphine administration. However, in PAG, in contrast to brainstem, superactivation of AC was observed in morphine-treated mice in comparison to controls (p<0.05). In conclusion, tolerance to morphine-induced respiratory effects is much more limited than tolerance to its analgesic effects in repeatedly morphine-treated mice. The difference in morphine-induced AC activation between the brainstem and the PAG contributes to the observed difference in tolerance between both morphine effects.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23296104     DOI: 10.1016/j.toxlet.2012.12.021

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  10 in total

1.  Effect of chronic γ-hydroxybutyrate (GHB) administration on GHB toxicokinetics and GHB-induced respiratory depression.

Authors:  Bridget L Morse; Gurkishan S Chadha; Melanie A Felmlee; Kristin E Follman; Marilyn E Morris
Journal:  Am J Drug Alcohol Abuse       Date:  2017-06-29       Impact factor: 3.829

2.  The mGluR5 antagonist fenobam induces analgesic conditioned place preference in mice with spared nerve injury.

Authors:  Neil C Lax; David C George; Christopher Ignatz; Benedict J Kolber
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

Review 3.  Opioid receptor desensitization: mechanisms and its link to tolerance.

Authors:  Stéphane Allouche; Florence Noble; Nicolas Marie
Journal:  Front Pharmacol       Date:  2014-12-18       Impact factor: 5.810

4.  Methadone Reverses Analgesic Tolerance Induced by Morphine Pretreatment.

Authors:  Luca Posa; Alison Accarie; Florence Noble; Nicolas Marie
Journal:  Int J Neuropsychopharmacol       Date:  2016-06-29       Impact factor: 5.176

Review 5.  Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine.

Authors:  Florence Noble; Nicolas Marie
Journal:  Front Psychiatry       Date:  2019-01-18       Impact factor: 4.157

Review 6.  Biased Opioid Ligands: Revolution or Evolution?

Authors:  Florence Noble; Nicolas Marie
Journal:  Front Pain Res (Lausanne)       Date:  2021-09-24

7.  Differential Effects of a Novel Opioid Ligand UTA1003 on Antinociceptive Tolerance and Motor Behaviour.

Authors:  Alok K Paul; Krystel L Woolley; Mohammed Rahmatullah; Polrat Wilairatana; Jason A Smith; Nuri Gueven; Nikolas Dietis
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-24

8.  Bifunctional peptide-based opioid agonist/nociceptin antagonist ligand for dual treatment of nociceptive and neuropathic pain.

Authors:  Camille Lagard; Lucie Chevillard; Karel Guillemyn; Patricia Risède; Jean-Louis Laplanche; Mariana Spetea; Steven Ballet; Bruno Mégarbane
Journal:  Pain       Date:  2017-03       Impact factor: 7.926

9.  PolyMorphine provides extended analgesic-like effects in mice with spared nerve injury.

Authors:  Neil C Lax; Renxun Chen; Sarah R Leep; Kathryn Uhrich; Lei Yu; Benedict Kolber
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

10.  Tolerance to Opioid-Induced Respiratory Depression in Chronic High-Dose Opioid Users: A Model-Based Comparison With Opioid-Naïve Individuals.

Authors:  Marijke Hyke Algera; Erik Olofsen; Laurence Moss; Robert L Dobbins; Marieke Niesters; Monique van Velzen; Geert Jan Groeneveld; Jules Heuberger; Celine M Laffont; Albert Dahan
Journal:  Clin Pharmacol Ther       Date:  2020-10-05       Impact factor: 6.875

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.